VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 112 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $140,000 | -25.9% | 12,818 | -23.1% | 0.00% | – |
| Q1 2022 | $189,000 | -88.1% | 16,664 | -86.2% | 0.00% | -100.0% |
| Q4 2020 | $1,590,000 | -40.1% | 121,010 | -56.0% | 0.01% | -47.1% |
| Q3 2020 | $2,655,000 | +130.3% | 274,854 | +172.7% | 0.02% | +112.5% |
| Q2 2020 | $1,153,000 | -82.8% | 100,793 | -84.4% | 0.01% | -88.1% |
| Q1 2020 | $6,708,000 | -11.5% | 647,460 | +40.2% | 0.07% | +28.8% |
| Q4 2019 | $7,576,000 | +24.8% | 461,691 | +1.0% | 0.05% | +8.3% |
| Q3 2019 | $6,071,000 | +742.0% | 457,145 | +793.4% | 0.05% | +700.0% |
| Q2 2019 | $721,000 | – | 51,170 | +182650.0% | 0.01% | – |
| Q1 2019 | $0 | -100.0% | 28 | -100.0% | 0.00% | -100.0% |
| Q3 2018 | $3,986,000 | +430.1% | 173,670 | +193.2% | 0.02% | +70.0% |
| Q2 2015 | $752,000 | +521.5% | 59,233 | +354.8% | 0.01% | +400.0% |
| Q1 2015 | $121,000 | -95.6% | 13,024 | -92.3% | 0.00% | -96.0% |
| Q1 2014 | $2,764,000 | – | 170,104 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |